Investors seem to be mounting bets against some biotech and pharma names, including one that has soared in 2022.
Short interest in Verve rose to 12 million shares, or 34% of its float, while 27.6 million shares of Allogene were being shorted through the end of September.
Retailers Bed Bath & Beyond and Big Lots, along women's fashion company Torrid Holdings, also saw increased short interest.
Short interest data is updated twice a month and reported mid-month and at the end of the month.
The next release date is Oct. 25 for short interest data as of Oct. 14).